CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to create macrophage-mimicking nanocarriers for targeted delivery of dexamethasone to treat Inflammatory Bowel Disease. By enhancing drug delivery efficiency and reducing side effects, the project seeks to advance nanomedicine and improve therapies for chronic inflammatory conditions.
In this project, we propose to develop innovative macrophage-mimicking nanocarriers (MMCs) with fusogenic properties (FMMCs) for the targeted delivery of dexamethasone to inflammation sites, particularly for treating Inflammatory Bowel Disease (IBD).
These nanocarriers, designed to mimic the natural targeting abilities of macrophages, aim to enhance therapeutic efficacy and reduce systemic side effects.To achieve this, we will first synthesize and optimize MMCs, incorporating fusogenic propertie…
UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
